Danaher Co. (NYSE:DHR) Shares Sold by White Pine Capital LLC

White Pine Capital LLC decreased its holdings in Danaher Co. (NYSE:DHR) by 6.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,217 shares of the conglomerate’s stock after selling 220 shares during the period. White Pine Capital LLC’s holdings in Danaher were worth $738,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also modified their holdings of DHR. Heck Capital Advisors LLC purchased a new position in Danaher in the fourth quarter worth approximately $27,000. Decker Retirement Planning Inc. acquired a new stake in shares of Danaher in the 4th quarter valued at $31,000. Golden State Wealth Management LLC purchased a new stake in shares of Danaher during the 4th quarter worth $31,000. Strategic Financial Concepts LLC acquired a new position in shares of Danaher during the fourth quarter worth $31,000. Finally, Pineridge Advisors LLC increased its holdings in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after buying an additional 57 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is owned by corporate insiders.

Danaher Stock Up 0.7 %

Shares of Danaher stock opened at $203.56 on Friday. The company has a market cap of $147.03 billion, a P/E ratio of 38.55, a PEG ratio of 2.68 and a beta of 0.83. The firm has a fifty day moving average of $230.49 and a two-hundred day moving average of $250.28. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a one year low of $196.80 and a one year high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the company earned $2.09 earnings per share. On average, analysts forecast that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.53%. The ex-dividend date was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Royal Bank of Canada reaffirmed an “outperform” rating and set a $277.00 price target (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. UBS Group decreased their target price on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Guggenheim initiated coverage on shares of Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target on the stock. Wells Fargo & Company reduced their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Finally, Stephens reaffirmed an “overweight” rating and issued a $315.00 target price on shares of Danaher in a research report on Wednesday, October 23rd. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.